Insider trades
Robert Michael Dudley, CEO of Transcode Therapeutics RNAZ, has filed 5 purchases and 0 sales on the open market. The latest trade was on 23/09/28.
Robert Michael Dudley
CEO
- Company
- Transcode Therapeutics RNAZ
- First filing
- 23/05/19
- Trades
- 6 trades
- Buys / sales
- 5 / 0
- 12-month net buying
- No record
- Last trade
- 23/09/28
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 23/09/28 | 23/10/02 | 98,000 sh | $0.51 | $49,980 | +119.1% | |
RNAZ | Open-market buy | 23/06/20–23/06/21 | 23/06/22 | 18,607 sh2 trades | $2.61avg. | $48,647.85 | +29.2% |
| Open-market buyAmendment | 23/06/09 | 23/06/14 | 19,000 sh | $2.76 | $52,440 | +45.1% | |
| Open-market buy | 23/06/09 | 23/06/13 | 19,000 sh | $2.76 | $52,440 | +2.1% |